Insights into myopic choroidal neovascularization based on quantitative proteomics analysis of the aqueous humor

BMC Genomics

Table 2 Comparison of clinical characteristics between pmCNV eyes and non-CNV eyes

	G1 group (pmCNV)	G2 group (MAM)	G3 group (non-MM)	P-g1g2
No. of eyes	12	6	6
Age	61.17 ± 9.54	48.50 ± 3.62	47.17 ± 6.11	0.007	0.009
AL	29.61 ± 1.84	31.18 ± 3.12	28.19 ± 1.95	0.261	0.092
Gender/Female	8 (66.7%)	4 (66.7%)	3 (50.0%)	1.000	0.627
Bilateral/OD	6 (50.0%)	2 (33.3%)	4 (66.7%)	0.638	0.638
A lesion				0.308	0.006
0	0 (0.0%)	0 (0.0%)	2 (33.3%)
1	1 (8.3%)	0 (0.0%)	4 (66.7%)
2	4 (33.3%)	4 (66.7%)	0 (0.0%)
3	3 (25.0%)	2 (33.3%)	0 (0.0%)
4	4 (33.3%)	0 (0.0%)	0 (0.0%)
T lesion				0.057	0.070
0	5 (41.7%)	6 (100.0%)	6 (100.0%)
1	5 (41.7%)	0 (0.0%)	0 (0.0%)
2	2 (16.7%)	0 (0.0%)	0 (0.0%)
N lesion				< 0.001	< 0.001
0	0 (0.0%)	6 (100.0%)	6 (100.0%)
2a	12 (100.0%)	0 (0.0%)	0 (0.0%)

P-g1g2 was derived from a comparison between the G1 group (pmCNV) and the G2 group (MAM).
P-g1g3 was derived from a comparison between the G1 group (pmCNV) and the G3 group (non-MM).

ISSN: 1471-2164